KU Hematology & Medical Oncology Review 2019
R

KU ASCO GU 2019 Updates: Enzalutamide vs. Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer and Enfortumab in Metastatic Bladder Cancer

By KU Hematology & Medical Oncology Review 2019 FEATURING Rahul Parikh
By KU Hematology & Medical Oncology Review 2019 FEATURING Rahul Parikh
838 views
August 22, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

21:17
Janssen Oncology

The Man Cave

Feat. J. Hamilton, M. Fabrizio, M. Taha

Featured Video

19:22
Janssen Oncology

Doc Talk Podcast

Feat. J. Hamilton, M. Fabrizio, M. Taha

Related Content

AUTOPLAY
11:56
Ana Aparicio

Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment…

14:16
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Mes…

Feat. E. Efstathiou
09:14
Robert Dreicer

AUA Advanced Prostate Cancer Guidelines: 2023 Update

16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
27:04
Fengting Yan

Cancer Screening Molecular Tools

15:58
Total Health

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Feat. M. Reimers
05:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare …

Feat. S. Tagawa
08:05
Total Health

Prostate Cancer Updates From ASCO® 2023

Feat. T. Zhang
11:39
Oncology Data Advisor

Recent Prostate Cancer Updates

Feat. U. Vaishampayan
21:17
Manish Kohli

Time to Castrate Resistance in mCSPC Using Standard of Care Intensif…

19:07
Stanford Medicine

Stanford Medicine Advances in Imaging to Improve Prostate Cancer Dia…

Feat. G. Sonn
09:45
Northwestern Medicine Oncology and Hematology

Differences Between Urologists and Medical Oncologists in the Manage…

Feat. W. Catalona
25:33
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute Prostate Cancer Updates From ASCO GU 20…

Feat. J. Berchuck, A. Choudhury
12:39
ASCO GU 2023 Conference Coverage

Efficacy and Safety of Darolutamide in Combination With ADT and Doce…

Feat. C. Sternberg
10:13
Judd Moul

Treatment Intensification in Advanced Prostate Cancer

10:12
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 Randomized EMBARK Study - Enzaluta…

Feat. S. Freedland
14:51
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Tailoring Prostate Cancer Care - EMBARK…

Feat. S. Freedland
11:12
E. David Crawford

Phase 3 ARASENS Trial: Overall Safety & Incidences of Adverse Ev…

11:29
Oncology Data Advisor

Enfortumab Vedotin + Pembro for Previously Untreated Advanced Urothe…

Feat. T. Powles
34:43
OncoAlert

Year in Review: Therapeutic Advances in Prostate Cancer

Feat. N. Agarwal